Ranganathan S - Search Results

1

Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.

Cohen SJ, Ho L, Ranganathan S, Abbruzzese JL, Alpaugh RK, Beard M, Lewis NL, McLaughlin S, Rogatko A, Perez-Ruixo JJ, Thistle AM, Verhaeghe T, Wang H, Weiner LM, Wright JJ, Hudes GR, Meropol NJ. Cohen SJ, et al. Among authors: ranganathan s. J Clin Oncol. 2003 Apr 1;21(7):1301-6. doi: 10.1200/JCO.2003.08.040. J Clin Oncol. 2003. PMID: 12663718 Clinical Trial.

2

Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.

Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, Langer CJ, Litwin S, Yeslow G, Halberr T, Qian M, Gallo JM. Hudes GR, et al. Among authors: ranganathan s. Clin Cancer Res. 2000 Aug;6(8):3071-80. Clin Cancer Res. 2000. PMID: 10955786 Clinical Trial.

3

Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.

Ranganathan S, McCauley RA, Dexter DW, Hudes GR. Ranganathan S, et al. Br J Cancer. 2001 Sep 1;85(5):735-40. doi: 10.1054/bjoc.2001.1956. Br J Cancer. 2001. PMID: 11531260 Free PMC article.

4

Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.

Ranganathan S, Dexter DW, Benetatos CA, Hudes GR. Ranganathan S, et al. Biochim Biophys Acta. 1998 Jan 21;1395(2):237-45. doi: 10.1016/s0167-4781(97)00168-1. Biochim Biophys Acta. 1998. PMID: 9473684

5

Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.

Ranganathan S, Dexter DW, Benetatos CA, Chapman AE, Tew KD, Hudes GR. Ranganathan S, et al. Cancer Res. 1996 Jun 1;56(11):2584-9. Cancer Res. 1996. PMID: 8653701

6

Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy.

Ranganathan S, Salazar H, Benetatos CA, Hudes GR. Ranganathan S, et al. Prostate. 1997 Mar 1;30(4):263-8. doi: 10.1002/(sici)1097-0045(19970301)30:4<263::aid-pros6>3.0.co;2-m. Prostate. 1997. PMID: 9111604

7

Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.

Ranganathan S, Benetatos CA, Colarusso PJ, Dexter DW, Hudes GR. Ranganathan S, et al. Br J Cancer. 1998 Feb;77(4):562-6. doi: 10.1038/bjc.1998.91. Br J Cancer. 1998. PMID: 9484812 Free PMC article.

8

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.

Cristofanilli M, Johnston SR, Manikhas A, Gomez HL, Gladkov O, Shao Z, Safina S, Blackwell KL, Alvarez RH, Rubin SD, Ranganathan S, Redhu S, Trudeau ME. Cristofanilli M, et al. Among authors: ranganathan s. Breast Cancer Res Treat. 2013 Jan;137(2):471-82. doi: 10.1007/s10549-012-2369-x. Epub 2012 Dec 13. Breast Cancer Res Treat. 2013. PMID: 23239151 Free PMC article. Clinical Trial.

9

Glyoxalase I in detoxification: studies using a glyoxalase I transfectant cell line.

Ranganathan S, Walsh ES, Tew KD. Ranganathan S, et al. Biochem J. 1995 Jul 1;309 ( Pt 1)(Pt 1):127-31. doi: 10.1042/bj3090127. Biochem J. 1995. PMID: 7619046 Free PMC article.

10

Influence of ethacrynic acid on glutathione S-transferase pi transcript and protein half-lives in human colon cancer cells.

Shen H, Ranganathan S, Kuzmich S, Tew KD. Shen H, et al. Among authors: ranganathan s. Biochem Pharmacol. 1995 Oct 12;50(8):1233-8. doi: 10.1016/0006-2952(95)00263-y. Biochem Pharmacol. 1995. PMID: 7488239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,048 results

Search Page

Filters